North Little Rock, Arkansas Clinical Trials

A listing of North Little Rock, Arkansas clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 5 clinical trials
A Study to Assess AMG 701 Montherapy or in Combination With Pomalidomide With or Without Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

The primary purpose of the phase 1 part of the study is to evaluate safety and tolerability of AMG 701 monotherapy to identify the RP2D for AMG 701 monotherapy followed by a dose-confirmation part to gather further safety data for AMG 701 monotherapy at the RP2D in adult subjects with …

Research Site
 (4.6 away) Contact site
  • 252 views
  • 14 Jun, 2021
  • +73 other locations
A Pharmacokinetic Study of Tedizolid Phosphate in Pediatric Participants With Gram-Positive Infections (MK-1986-014)

The primary objectives of this study are to describe the single-dose, and multiple dose pharmacokinetics (PK) of intravenous (IV) tedizolid phosphate, or a single dose oral suspension of tedizolid phosphate, when administered to pediatric participants, full-term neonates, and preterm neonates.

Arkansas Children's Hospital ( Site 1012)
 (2.3 away) Contact site
  • 39 views
  • 19 Jun, 2021
  • +28 other locations
A Study to Assess the Pharmacokinetics (PK) and Safety of Staccato Alprazolam in Adolescent Study Participants With Epilepsy

The purpose of the study is to assess the pharmacokinetics (PK), tolerability, and safety of Staccato alprazolam in adolescent study participants with epilepsy following single-dose administration.

antiepileptics
generalized epilepsy
Up0100 102
 (5.1 away) Contact site
  • 0 views
  • 15 Jun, 2021
  • +3 other locations
Study of ISB 1342 a CD38/CD3 Bispecific Antibody in Subjects With Previously Treated Multiple Myeloma

The purpose of this study is to assess safety, efficacy, pharmacokinetic (PK)/pharmacodynamic (PD), and immunogenicity with ISB 1342 in subjects with relapsed/refractory multiple myeloma.

measurable disease
monoclonal antibodies
refractory multiple myeloma
monoclonal protein
daratumumab
Glenmark Investigational Site 2
 (4.6 away) Contact site
  • 57 views
  • 12 Jun, 2021
  • +25 other locations
AMG 334 20160172 Pediatric Migraine PK Study.

AMG 334 20160172 Pediatric Migraine PK Study.

headache
Research Site
 (2.3 away) Contact site
  • 309 views
  • 23 Jun, 2021
  • +24 other locations